Smart science to improve lives™


Croda creates long-term value by engaging with our customers and markets wherever and whenever they need us - creating, making and selling sustainable and innovative speciality ingredients. We call this Smart science to improve lives™.

Find out more


We provide practical solutions to help address some of the world’s biggest challenges and are committed to becoming the most sustainable supplier of innovative ingredients. As part of this we will become Climate, Land and People Positive by 2030, having used the United Nations Sustainable Development Goals (SDGs) to underpin our approach.

This section tells you more about our goals, how we are achieving them, and the successes we have already achieved.

Contact Croda investor relations

Institutional investors

Please contact our Investor Relations team by email

Individual investors

Individual shareholder queries are dealt with by our Registrars, Link Asset Services. Contact details can be found in our shareholder information centre.

Case study: Improving the customer experience in China

Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.

Financial performance and KPIs

View our most recent financial results and key performance indicators.

Results, presentations and reports

View our results collateral and archive.

Financial results and past events

Half year 2022 results

Excellent first half performance driving profit growth

Find out more

Half year 2022 results

Listen on demand to our half year results, 29 July 2022

Listen on demand

Investor news

Sustainability expert Aris Vrettos joins Croda

The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...

Read more
Laboratory work

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

Read more

U.S. Government to support expansion of Croda lipid systems capability

Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines

Read more

Sustainability success with EcoVadis rating

24 May 2022: Sustainability success after retaining its position within the top 1% of companies assessed by EcoVadis

Read more

Environmental, Social and Governance (ESG)

Useful links to further information on our environmental, governance and social impact.

Stock exchange announcements

Our most recent announcements to the stock exchange.

Annual Report

During 2021, the strength and quality of our business model has been further demonstrated.

Shareholder centre

Useful information for Croda Shareholders.

Croda labs

Investment case

Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.

Events centre

Collateral and information from our regular shareholder events.